NDC11 63561012702
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63561-0127-02 | 63561-0127 |
| 63561-0127-2 | 63561-0127 |
| 63561-127-02 | 63561-127 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carisoprodol Tablets, USP, 350 mg | CARISOPRODOL | Granulation Technology, Inc. | 2abd11e4-8ce4-4aeb-87c4-3af94c197714 | 2025-06-11 | Warnings, Adverse reactions | 63561-0127-2 63561-0127 63561012702 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.